
-
'Ketamine Queen' to plead guilty over drugs that killed Matthew Perry
-
Guirassy sends struggling Dortmund past Essen in German Cup
-
Stocks under pressure as Zelensky-Trump talks underway
-
Alcaraz wins Cincinnati Open as Sinner retires
-
Trump floats Ukraine security pledges in talks with Zelensky and Europeans
-
Doak joins Bournemouth as Liverpool exodus grows
-
Excessive force used against LA protesters: rights group
-
Panama hopes to secure return of US banana giant Chiquita
-
'Things will improve': Bolivians look forward to right's return
-
Trump welcomes Zelensky with fresh optimism on peace deal
-
Israeli controls choke Gaza relief at Egypt border, say aid workers
-
Air Canada flight attendants vow to defy latest back-to-work order
-
Hurricane Erin drenches Caribbean islands, threatens US coast
-
Europeans arrive for high-stakes Trump and Zelensky talks
-
Trump, Zelensky and Europeans meet in bid to resolve split over Russia
-
Hamas accepts new Gaza truce plan: Hamas official
-
Stocks under pressure ahead of Zelensky-Trump talks
-
Russian attacks kill 14 in Ukraine ahead of Trump-Zelensky talks
-
Lassana Diarra seeks 65 mn euros from FIFA and Belgian FA in transfer case
-
Air Canada flight attendants face new pressure to end strike
-
Alonso says 'no excuses' as Real Madrid prepare for La Liga opener
-
Deadly wildfires rage across Spain as record area of land burnt
-
Swedish ex-govt adviser goes on trial over mislaid documents
-
Injured Springboks captain Kolisi out for four weeks
-
Irish literary star Sally Rooney pledges UK TV fees to banned pro-Palestine group
-
Stocks mixed ahead of Trump-Zelensky talks
-
Son of Norway princess charged with four rapes
-
Fresh Pakistan monsoon rains kill 20, halt rescue efforts
-
Forest sign French forward Kalimuendo
-
Zelensky warns against 'rewarding' Russia after Trump urges concessions
-
FIFA boss condemns racial abuse in German Cup games
-
Stocks diverge ahead of Trump-Zelensky talks
-
Spain and Portugal battle wildfires as death toll mounts
-
Joao Felix says late Jota 'will forever be part of football history'
-
Javelin star Kitaguchi finds new home in small Czech town
-
Rain halts rescue operation after Pakistan floods kill hundreds
-
Zelensky says Russia must end war, after Trump pressures Ukraine
-
China slams Germany for 'hyping' regional tensions in Asia
-
US envoy says Israel's turn to 'comply' as Lebanon moves to disarm Hezbollah
-
Asia stocks up before Trump-Zelensky talks
-
Fight to save last forests of the Comoros unites farmers, NGOs
-
Hong Kong court hears closing arguments in tycoon Jimmy Lai's trial
-
Five killed in Russian drone attack on Ukraine apartment block
-
Myanmar junta sets December 28 poll date despite raging civil war
-
German minister says China 'increasingly aggressive'
-
Singapore key exports slip in July as US shipments tumble 42.7 pct
-
German great Mueller has goal ruled out on MLS debut for Vancouver
-
Zelensky, European leaders head to US for talks on peace deal terms
-
Tourism deal puts one of Egypt's last wild shores at risk
-
Two right-wing candidates headed to Bolivia presidential run-off

SelectQuote (SLQT) Shares Slide Further on Disappointing Earnings Amidst DOJ Scrutiny - Hagens Berman
SLQT Investors with Losses Encouraged to Contact the Firm
SAN FRANCISCO, CA / ACCESS Newswire / June 17, 2025 / SelectQuote Inc. (NYSE:SLQT) faced renewed investor pressure on Monday, May 12, 2025, as its shares tumbled another 12% following the release of quarterly results that fell short of earnings and revenue expectations. This decline compounds the over 19% drop experienced on May 1st after the U.S. Department of Justice (DOJ) announced a lawsuit alleging violations of the False Claims Act against the insurance brokerage and several major health insurers.
Hagens Berman is investigating potential violations of the U.S. securities laws and encourages SelectQuote investors who suffered substantial losses to submit your losses now. The firm also urges persons with knowledge who may be able to assist in the investigation to contact its attorneys.
Visit: www.hbsslaw.com/investor-fraud/slqt
Contact the Firm Now: [email protected]
844-916-0895
Earnings Miss Adds to Investor Woes
For the quarter ended March 2025, SelectQuote reported earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. The company also posted revenues of $408.16 million, falling short of the Zacks Consensus Estimate of $417.01 million by 2.12%.
Mounting Troubles Weigh on Investor Confidence
This financial disappointment adds to the headwinds facing SelectQuote, which is already grappling with serious legal allegations. The DOJ lawsuit, unveiled on May 1st, accuses SelectQuote, along with other brokers and health insurance giants Aetna, Anthem, and Humana, of False Claims Act violations related to the marketing of Medicare Advantage (MA) plans.
The lawsuit alleges that, from 2016 through at least 2021, insurers paid significant sums to SelectQuote and other brokers for Medicare Advantage enrollments. The DOJ contends that, rather than providing unbiased guidance, SelectQuote and other brokers steered beneficiaries toward plans offering the highest commissions, potentially disregarding the suitability of those plans. The complaint further details allegations of incentivizing sales based on these commissions, establishing dedicated sales teams for specific high-commission plans, and instances of allegedly refusing to sell plans from insurers with lower commission structures. Discrimination against MA beneficiaries with disabilities is also alleged.
Hagens Berman's Investigation
The confluence of a weaker-than-anticipated earnings report and ongoing legal entanglements has amplified anxieties surrounding SelectQuote's financial stability and operational integrity. According to Reed Kathrein, the Hagens Berman partner spearheading an inquiry into the company, "The recent earnings figures underscore our existing concerns about SelectQuote's alleged steering tactics in light of the DOJ's allegations."
If you invested in SelectQuote and have substantial losses, or have knowledge that may assist the firm's investigation, submit your losses now »
If you'd like more information and answers to frequently asked questions about the SelectQuote investigation, read more »
Whistleblowers: Persons with non-public information regarding SelectQuote should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].
# # #
About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
Contact:
Reed Kathrein, 844-916-0895
SOURCE: Hagens Berman Sobol Shapiro LLP
View the original press release on ACCESS Newswire
Y.Aukaiv--AMWN